Page last updated: 2024-09-03

sdz nvi-085 and Disease Models, Animal

sdz nvi-085 has been researched along with Disease Models, Animal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dement, WC; Guilleminault, C; Mignot, E; Nishino, S; Renaud, A	1

Other Studies

1 other study(ies) available for sdz nvi-085 and Disease Models, Animal

Article	Year
Effects of SDZ NVI-085, a putative subtype-selective alpha 1-agonist, on canine cataplexy, a disorder of rapid eye movement sleep. European journal of pharmacology, 1991, Nov-19, Volume: 205, Issue:1 Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Body Temperature; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Cataplexy; Disease Models, Animal; Dogs; Eating; Heart Rate; Narcolepsy; Oxazines; Play and Playthings; Prazosin; Radioligand Assay; Yohimbine	1991

Article

Year

Effects of SDZ NVI-085, a putative subtype-selective alpha 1-agonist, on canine cataplexy, a disorder of rapid eye movement sleep.

European journal of pharmacology, 1991, Nov-19, Volume: 205, Issue:1

Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Body Temperature; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Cataplexy; Disease Models, Animal; Dogs; Eating; Heart Rate; Narcolepsy; Oxazines; Play and Playthings; Prazosin; Radioligand Assay; Yohimbine

1991